ESIKA - 13537-363-02 - (ENSULIZOLE, OCTINOXATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE, and TITANIUM DIOXIDE)

Alphabetical Index


Drug Information of ESIKA

Product NDC: 13537-363
Proprietary Name: ESIKA
Non Proprietary Name: ENSULIZOLE, OCTINOXATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE, and TITANIUM DIOXIDE
Active Ingredient(s): .03; .075; .05; .07; .6; .0468    g/g; g/g; g/g; g/g; g/g; g/g & nbsp;   ENSULIZOLE, OCTINOXATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE, and TITANIUM DIOXIDE
Administration Route(s): TOPICAL
Dosage Form(s): CREAM
Coding System: National Drug Codes(NDC)

Labeler Information of ESIKA

Product NDC: 13537-363
Labeler Name: Ventura Corporation (San Juan, P.R)
Product Type: HUMAN OTC DRUG
FDA Application Number: part352
Marketing Category: OTC MONOGRAPH NOT FINAL
Start Marketing Date: 20110530

Package Information of ESIKA

Package NDC: 13537-363-02
Package Description: 1 g in 1 BOTTLE (13537-363-02)

NDC Information of ESIKA

NDC Code 13537-363-02
Proprietary Name ESIKA
Package Description 1 g in 1 BOTTLE (13537-363-02)
Product NDC 13537-363
Product Type Name HUMAN OTC DRUG
Non Proprietary Name ENSULIZOLE, OCTINOXATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE, and TITANIUM DIOXIDE
Dosage Form Name CREAM
Route Name TOPICAL
Start Marketing Date 20110530
Marketing Category Name OTC MONOGRAPH NOT FINAL
Labeler Name Ventura Corporation (San Juan, P.R)
Substance Name ENSULIZOLE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE; TITANIUM DIOXIDE
Strength Number .03; .075; .05; .07; .6; .0468
Strength Unit g/g; g/g; g/g; g/g; g/g; g/g
Pharmaceutical Classes

Complete Information of ESIKA


General Information